Chris E. Rivera is currently the President, CEO and Chairman of the Board of Nativis Inc. He has over 30 years’ experience in the development and manufacturing of pharmaceutical and medical devices.

Whilst at the Washington Biotechnology and Biomedical Association he established the commercialization programs of more than 400 emerging biotechnology companies. Chris was the Founder and CEO of Hyperion Therapeutics Inc. which was acquired by Horizon Pharma in 2015. He was the Senior Vice President, Commercial Operations of Tercica Inc. where he was responsible for strategic planning, and at Corixa Inc. he was the Vice President and oversaw the re-launch of BEXXAR. During his time as Senior Vice President at Genzyme Corporation, Chris initiated and built up the US renal division and implemented strategic alliances with key corporate partners.

Chris graduated with a BS/BA from Northwestern Oklahoma State University, a Master’s degree from the University of Oklahoma Health Science Center and studied at the Albers Graduate School of Business and Economics.